Replimune Group, Inc. 4 Filing

From the Filing

EDGAR Filing Documents for 0001104659-26-040570 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001104659-26-040570 Filing Date 2026-04-07 Accepted 2026-04-07 21:09:02 Documents 1 Period of Report 2026-04-01 Document Format Files Seq Description Document Type Size 1 OWNERSHIP DOCUMENT tm2611350-4_4seq1.html 4 1 OWNERSHIP DOCUMENT tm2611350-4_4seq1.xml 4 4118 Complete submission text file 0001104659-26-040570.txt 5509 Mailing Address 39 BLISS AVENUE TENAFLY NJ 07670 Business Address Dhingra Kapil ( Reporting ) CIK : 0001456849 (see all company filings) Type: 4 | Act: 34 | File No.: 001-38596 | Film No.: 26846262 Mailing Address 500 UNICORN PARK WOBURN MA 01801 Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600 Replimune Group, Inc. ( Issuer ) CIK : 0001737953 (see all company filings) EIN. : 822082553 | State of Incorp.: DE | Fiscal Year End: 0331 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)